{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:42:37Z","timestamp":1794213757202,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clinre.2025.102692","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:54:58Z","timestamp":1758786898000},"page":"102692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of dynamic changes in multiple serum tumor markers during neoadjuvant therapy on clinical outcome in gastrointestinal cancer"],"prefix":"10.1016","volume":"49","author":[{"given":"Fengchun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiande","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hechao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2025.102692_bib0001","article-title":"Global burden of five major types of gastrointestinal cancer","author":"Singh","year":"2024","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.clinre.2025.102692_bib0002","series-title":"Gastrointestinal malignancies","first-page":"407","year":"2023"},{"issue":"2","key":"10.1016\/j.clinre.2025.102692_bib0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/gastro\/goab010","article-title":"Gastrointestinal cancers in China, the USA, and Europe","volume":"9","author":"Xie","year":"2021","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"10.1016\/j.clinre.2025.102692_bib0004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10120-012-0148-3","article-title":"Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America","volume":"16","author":"Knight","year":"2013","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.clinre.2025.102692_bib0005","series-title":"ESMO living guideline: gastric cancer \u2014 peri\u2011operative chemotherapy","year":"2024"},{"issue":"19","key":"10.1016\/j.clinre.2025.102692_bib0006","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative chemoradiotherapy for resectable gastric cancer","volume":"391","author":"Leong","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2025.102692_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/tgh-24-57","article-title":"KEYNOTE-585: disappointing results for perioperative pembrolizumab in gastric cancer","volume":"10","author":"Ilson","year":"2024","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2025.102692_bib0008","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy as perioperative therapy in locally advanced gastric and gastroesophageal junction cancer: final analysis of the randomized, phase III KEYNOTE-585 study","author":"Shitara","year":"2025","journal-title":"Journal of clinical oncology: official journal of the American Society of YClinical Oncology"},{"issue":"3","key":"10.1016\/j.clinre.2025.102692_bib0009","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2503701","article-title":"Perioperative durvalumab in gastric and gastroesophageal junction cancer","volume":"393","author":"Janjigian","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clinre.2025.102692_bib0010","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.22.00046","article-title":"Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial","volume":"41","author":"Morton","year":"2023","journal-title":"J Clin Oncol: Official J Am Society Clin Oncol"},{"key":"10.1016\/j.clinre.2025.102692_bib0011","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11864-024-01184-6","article-title":"Preoperative strategies for locally advanced colon cancer","volume":"25","author":"Nair","year":"2024","journal-title":"Curr Treat Options Oncol"},{"issue":"25","key":"10.1016\/j.clinre.2025.102692_bib0012","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1200\/JCO.23.01889","article-title":"Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase III OPTICAL trial","volume":"42","author":"Hu","year":"2024","journal-title":"J Clin Oncol: Official J Am Society Clin Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102692_bib0013","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/DCR.0000000000002323","article-title":"The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of Colon cancer","volume":"65","author":"Vogel","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2025.102692_bib0014","series-title":"Biomarker discovery and validation for gastrointestinal tumors: a comprehensive review of colorectal, gastric, and liver cancers","author":"Hakami","year":"2024"},{"issue":"1","key":"10.1016\/j.clinre.2025.102692_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12937-9","article-title":"Impact of dynamic changes of tumor marker in neoadjuvant chemotherapy-treated triple-negative gastric cancer patients: a multi-center study","volume":"24","author":"Zheng","year":"2024","journal-title":"BMC Cancer"},{"issue":"51","key":"10.1016\/j.clinre.2025.102692_bib0016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jncimonographs\/lgv006","article-title":"Circulating biomarkers for prediction of treatment response","volume":"2015","author":"Cappelletti","year":"2015","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"10.1016\/j.clinre.2025.102692_bib0017","doi-asserted-by":"crossref","first-page":"779","DOI":"10.21037\/tcr-20-2560","article-title":"Dynamic monitoring of serum specific tumor markers predicts the response to PD-1 blockade and prognosis of patients with malignant tumors","volume":"10","author":"Dong","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"1","key":"10.1016\/j.clinre.2025.102692_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4987-0","article-title":"The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinre.2025.102692_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231206282","article-title":"Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study","volume":"15","author":"Yang","year":"2023","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102692_bib0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14216\/kjco.20018","article-title":"The prognostic value of postoperative tumor marker conversion for gastric cancer","volume":"16","author":"Noh","year":"2020","journal-title":"Korean J Clin Oncol"},{"key":"10.1016\/j.clinre.2025.102692_bib0021","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1477-7819-12-397","article-title":"Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy","volume":"12","author":"Sun","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.clinre.2025.102692_bib0022","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07666-8","article-title":"CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy","volume":"21","author":"Tong","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinre.2025.102692_bib0023","doi-asserted-by":"crossref","first-page":"8561","DOI":"10.1245\/s10434-023-14194-9","article-title":"Combined use of tumor markers in gastric cancer: a novel method with promising prognostic accuracy and practicality","volume":"30","author":"Zhang","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinre.2025.102692_bib0024","doi-asserted-by":"crossref","first-page":"35446","DOI":"10.18632\/oncotarget.9060","article-title":"Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.clinre.2025.102692_bib0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s10120-011-0091-8","article-title":"Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination","volume":"15","author":"Emoto","year":"2012","journal-title":"Gastric Cancer: Official J Int Gastric Cancer Assoc Japanese Gastric Cancer Assoc"},{"issue":"3","key":"10.1016\/j.clinre.2025.102692_bib0026","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4143\/crt.2004.36.3.178","article-title":"Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma","volume":"36","author":"Hwang","year":"2004","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clinre.2025.102692_bib0027","article-title":"Elevated preoperative CA125 is associated with poor survival in patients with metastatic colorectal cancer undergoing primary tumor resection: a retrospective cohort study","volume":"10","author":"Huang","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"47","key":"10.1016\/j.clinre.2025.102692_bib0028","doi-asserted-by":"crossref","first-page":"e5177","DOI":"10.1097\/MD.0000000000005177","article-title":"Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore"},{"issue":"4","key":"10.1016\/j.clinre.2025.102692_bib0029","article-title":"Evaluating biomarker dynamics in breast cancer Post-neoadjuvant chemotherapy: a retrospective cross-sectional study","volume":"11","author":"Kiruthikasri","year":"2024","journal-title":"Archiv Breast Cancer"},{"issue":"16","key":"10.1016\/j.clinre.2025.102692_bib0030","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1002\/cam4.4676","article-title":"Dynamic monitoring serum tumor markers to predict molecular features of EGFR-mutated lung cancer during targeted therapy","volume":"11","author":"Chen","year":"2022","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102692_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr960","article-title":"Biomarkers and predictive factors of response to neoadjuvant treatment","volume":"11","author":"Dowsett","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.clinre.2025.102692_bib0032","first-page":"321","article-title":"Clinical application of confidence interval for monitoring changes in tumor markers to determine the responsiveness to cancer treatment","volume":"51","author":"Cho","year":"2020","journal-title":"Ann Clin Lab Sci"},{"issue":"21","key":"10.1016\/j.clinre.2025.102692_bib0033","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.7150\/jca.60694","article-title":"CA724 Predicts tumor regression grade in locally advanced gastric cancer patients with neoadjuvant chemotherapy","volume":"12","author":"Tong","year":"2021","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.clinre.2025.102692_bib0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s10120-011-0091-8","article-title":"Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination","volume":"15","author":"Emoto","year":"2012","journal-title":"Gastric Cancer: Official J Int Gastric Cancer Assoc Japanese Gastric Cancer Assoc"},{"issue":"6","key":"10.1016\/j.clinre.2025.102692_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108367","article-title":"Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy","volume":"50","author":"Zhang","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.clinre.2025.102692_bib0036","article-title":"The changes and clinical significance of preoperative and postoperative serum CEA and CA19-9 in gastric cancer","volume":"66","author":"Jing","year":"2020","journal-title":"Clin Lab"},{"issue":"3","key":"10.1016\/j.clinre.2025.102692_bib0037","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41416-020-0901-z","article-title":"Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer","volume":"123","author":"Lin","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clinre.2025.102692_bib0038","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1477-7819-12-397","article-title":"Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy","volume":"12","author":"Sun","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"7","key":"10.1016\/j.clinre.2025.102692_bib0039","first-page":"1608","article-title":"Prognostic values of CEA, CA19-9, and CA72-4 in patients with stages I-III colorectal cancer","volume":"13","author":"Wu","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clinre.2025.102692_bib0040","doi-asserted-by":"crossref","unstructured":"Zhang, R., Chen, X., Chen, G., et al. (2023). Combined use of tumor markers in gastric cancer: a novel method with promising prognostic accuracy and practicality. [Preprint]. Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-2971637\/v1.","DOI":"10.21203\/rs.3.rs-2971637\/v1"},{"issue":"10","key":"10.1016\/j.clinre.2025.102692_bib0041","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12325-008-0100-4","article-title":"Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer","volume":"25","author":"U\u00e7ar","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinre.2025.102692_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4714910","article-title":"Disease biomarkers in gastrointestinal malignancies","volume":"2016","author":"Moaven","year":"2016","journal-title":"Dis Markers"},{"issue":"2","key":"10.1016\/j.clinre.2025.102692_bib0043","first-page":"162","article-title":"Apoptosis and gastrointestinal tract","volume":"31","author":"Ciccocioppo","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinre.2025.102692_bib0044","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/gut.2008.164350","article-title":"Novel ways to sensitise gastrointestinal cancer to apoptosis","volume":"58","author":"Schulze-Bergkamen","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2025.102692_bib0045","first-page":"12","article-title":"Molecular markers in gastrointestinal cancer: targeted therapy and tailored chemotherapy","volume":"27","author":"Lenz","year":"2004","journal-title":"Onkologie"},{"key":"10.1016\/j.clinre.2025.102692_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1018333","article-title":"Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment","volume":"12","author":"Sato","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.clinre.2025.102692_bib0047","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/ijms17071155","article-title":"Cellular and molecular mechanisms of 3,3\u2032-diindolylmethane in gastrointestinal cancer","volume":"17","author":"Kim","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012500169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012500169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:01:02Z","timestamp":1761966062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221074012500169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S221074012500169X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102692","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of dynamic changes in multiple serum tumor markers during neoadjuvant therapy on clinical outcome in gastrointestinal cancer","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102692"}}